Connection

George Lau to Coronavirus Infections

Back to Details
This is a "connection" page, showing publications George Lau has written about Coronavirus Infections.
George Lau
Connection Strength
0.159
Coronavirus Infections
  1. Effect of COVID-19 on patients with compensated chronic liver diseases. Hepatol Int. 2020 Sep; 14(5):701-710.
    View in: PubMed
    Score: 0.028
  2. Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'. J Hepatol. 2020 09; 73(3):722.
    View in: PubMed
    Score: 0.028
  3. Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'. J Hepatol. 2020 09; 73(3):718-719.
    View in: PubMed
    Score: 0.028
  4. Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation. Hepatol Int. 2020 Jul; 14(4):432-436.
    View in: PubMed
    Score: 0.027
  5. Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol. 2020 08; 73(2):451-453.
    View in: PubMed
    Score: 0.027
  6. Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score. Clin Infect Dis. 2020 09 12; 71(6):1393-1399.
    View in: PubMed
    Score: 0.007
  7. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020 Sep; 14(5):690-700.
    View in: PubMed
    Score: 0.007
  8. Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations. Hepatol Int. 2020 Jul; 14(4):415-428.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.